EFEarnings Feed

S

Company dossier

Solexa, Inc.

CIK 0000913275SIC 3826Laboratory Analytical Instruments

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

6 items

10-QAccepted Nov 11, 7:00 PM ETAcc 0000913275-99-000023
LYNX THERAPEUTICS INC69.9 KB
LYNX THERAPEUTICS INC 10-Q
View filing
10-QAccepted Aug 12, 8:00 PM ETAcc 0000913275-99-000018
LYNX THERAPEUTICS INC43.7 KB
LYNX THERAPEUTICS INC 10-Q
View filing
10-QAccepted May 16, 8:00 PM ETAcc 0000913275-99-000008
LYNX THERAPEUTICS INC35.8 KB
LYNX THERAPEUTICS INC 10-Q
View filing
10-QAccepted Nov 15, 7:00 PM ETAcc 0000913275-98-000005
LYNX THERAPEUTICS INC36.3 KB
LYNX THERAPEUTICS INC 10-Q
View filing
10-QAccepted Aug 11, 8:00 PM ETAcc 0000950005-98-000675
LYNX THERAPEUTICS INC51.4 KB
LYNX THERAPEUTICS INC 10-Q
View filing
8-KAccepted Jun 16, 8:00 PM ETAcc 0000950005-98-000545
LYNX THERAPEUTICS INC20.6 KB
LYNX THERAPEUTICS INC 8-K
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
25861 INDUSTRIAL BLVD
HAYWARD, CA, 94545
mailing
25861 INDUSTRIAL BLVD
HAYWARD, CA, 94545

Former names

LYNX THERAPEUTICS INC
1996-10-03 – 2005-02-22